000 | 01930 a2200553 4500 | ||
---|---|---|---|
005 | 20250516070814.0 | ||
264 | 0 | _c20120706 | |
008 | 201207s 0 0 eng d | ||
022 | _a1945-7197 | ||
024 | 7 |
_a10.1210/jc.2011-2486 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTriay, Jessica | |
245 | 0 | 0 |
_aDoes rimonabant independently affect free fatty acid and glucose metabolism? _h[electronic resource] |
260 |
_bThe Journal of clinical endocrinology and metabolism _cMar 2012 |
||
300 |
_a819-27 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aBehavior Therapy |
650 | 0 | 4 |
_aBody Composition _xdrug effects |
650 | 0 | 4 | _aCannabinoid Receptor Antagonists |
650 | 0 | 4 | _aDiet, Reducing |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aFatty Acids, Nonesterified _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucose _xmetabolism |
650 | 0 | 4 | _aGlucose Clamp Technique |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInsulin _xmetabolism |
650 | 0 | 4 |
_aIntra-Abdominal Fat _xdrug effects |
650 | 0 | 4 | _aLife Style |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMetabolic Syndrome _xdrug therapy |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aObesity _xdrug therapy |
650 | 0 | 4 |
_aPiperidines _xpharmacology |
650 | 0 | 4 |
_aPyrazoles _xpharmacology |
650 | 0 | 4 | _aRimonabant |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aWeight Loss _xdrug effects |
700 | 1 | _aMundi, Manpreet | |
700 | 1 | _aKlein, Samuel | |
700 | 1 | _aToledo, Frederico G | |
700 | 1 | _aSmith, Steven R | |
700 | 1 | _aAbu-Lebdeh, Haitham | |
700 | 1 | _aJensen, Michael | |
773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 97 _gno. 3 _gp. 819-27 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2011-2486 _zAvailable from publisher's website |
999 |
_c21392872 _d21392872 |